Skip to main content

. 1976 Feb;3(1 Suppl 1):73–74. doi: 10.1111/j.1365-2125.1976.tb03717.x

Hypotensive drugs in the treatment of depression.

PMCID: PMC2958726 PMID: 973949

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Hamilton M. Some aspects of the long-term treatment of severe hypertension with methyldopa. Postgrad Med J. 1968 Jan;44(507):66–69. doi: 10.1136/pgmj.44.507.66. [DOI] [PMC free article] [PubMed] [Google Scholar]
Johnson P., Kitchin A. H., Lowther C. P., Turner R. W. Treatment of hypertension with methyldopa. Br Med J. 1966 Jan 15;1(5480):133–137. doi: 10.1136/bmj.1.5480.133. [DOI] [PMC free article] [PubMed] [Google Scholar]
Oates J. A., Seligmann A. W., Clark M. A., Rousseau P., Lee R. E. The relative efficacy of guanethidine, methyldopa and pargyline as antihypertensive agents. N Engl J Med. 1965 Sep 30;273(14):729–734. doi: 10.1056/NEJM196509302731402. [DOI] [PubMed] [Google Scholar]
PLETSCHER A., SHORE P. A., BRODIE B. B. Serotonin as a mediator of reserpine action in brain. J Pharmacol Exp Ther. 1956 Jan;116(1):84–89. [PubMed] [Google Scholar]
SOKES T. L. THE ACTION OF ALPHA-METHYLDOPA IN THE BRAIN. Br Med Bull. 1965 Jan;21:66–69. doi: 10.1093/oxfordjournals.bmb.a070359. [DOI] [PubMed] [Google Scholar]
Snaith R. P., Ahmed S. N., Mehta S., Hamilton M. Assessment of the severity of primary depressive illness. Wakefield self-assessment depression inventory. Psychol Med. 1971 Feb;1(2):143–149. doi: 10.1017/s0033291700000064. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES